Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Academic Drug Discovery

Per Arvidsson's Biography



Per Arvidsson, Director, Karolinska Institutet

Per I Arvidsson is Director of the national Swedish Drug Discovery & Development Platform at Science for Life Laboratory (SciLifeLab DDD). He is also fractional research professor at the College of Heath Science, UKZN, South Africa. Before joining SciLifeLab & Karolinska Institutet in 2013 to set up the SciLifeLab DDD platform, Prof. Arvidsson held various roles at the CNS & Pain iMED at AstraZeneca, Södertälje, the last being Director for late stage pre-clinical and clinical neuroscience drug discovery. His accolades include several professorship positions at Uppsala University in Sweden and postdoctoral studies with Prof. D. Seebach at ETH Zurich, Switzerland. Prof. Arvidsson is named inventor on some 15+ patent applications, and co-author to some 100 peer-reviewed publications, two of which have won “most cited papers” awards.

Per Arvidsson Image

Open for Collaboration – An Academic Platform for Drug Discovery & Development at SciLifeLab

Monday, 6 March 2017 at 16:30

Add to Calendar ▼2017-03-06 16:30:002017-03-06 17:30:00Europe/LondonOpen for Collaboration – An Academic Platform for Drug Discovery and Development at SciLifeLabSELECTBIOenquiries@selectbiosciences.com

SciLifeLab DDD is a newly established national Swedish infrastructure for academic drug discovery. I will describe the build-up, operation, and international collaboration of the platform, with the ambition to share learnings and best practice with academic drug discovery centers globally.


Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAcademic Drug DiscoverySELECTBIOenquiries@selectbiosciences.com